期刊文献+

晚期非小细胞肺癌维持化疗的新进展 被引量:3

下载PDF
导出
摘要 化疗是晚期肺癌的主要治疗手段.第三代新药联合铂类的两药化疗方案是初治晚期非小细胞肺癌(NSCLC)的标准一线治疗方案,与最佳支持治疗比较,中位生存期延长2个月,1年生存率提高10%。
出处 《江西医药》 CAS 2009年第4期372-374,共3页 Jiangxi Medical Journal
  • 相关文献

参考文献10

  • 1mith IE, O 'Brien ME, Talbot DC ,et al. Duration of chemotherapy in advanced non-small-cell lung cancer:A randomized trial of three versus six courses of mitomycin, vinblastine,and cisplatin. J Clin Oncol 2001,19:1356
  • 2Socinski MA, Schell M J, Peterman A, et al. Phase Ⅲ trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage ⅢB/Ⅳ non-small-cell lung cancer. J Clin Oncol,2002,20:1335
  • 3Goldie JH, Coldman AJ.A mathematical model for relating the drug Sensitivity of tumors to theirs spontaneous mutation rate.Caneer Treat Rep,1979,63(11-12):1727
  • 4Day RS.Treatment sequencing,asymmetry,and uncertainty:protocol strategies for conrbination chemotherapy.Cancer Res,1986,46:3876
  • 5Fidias P, Dakhil SR, Lyss AP et al. Updated report of a phase Ⅲ study of induction therapy with gemeitabine + carboplatin (GC) followed by either delayed vs. immediate second-line therapy with docetaxel (D) in advanced non-small cell lung cancer. J Clin Oncol, 2006,24(18 Suppl):7032
  • 6Brodowicz T, Krzakowski M, Zwitter Met al. Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase Ⅲ trial.Lung Cancer, 2006,52:155
  • 7Ciuleanu TE, Brodowicz T, Belani CP, et al. Maintenance pemetrexed plus best supportive care (BSC) versus placebo plus BSC: A phase Ⅲ study. J Clin Oncol, 2008, 26: (Suppl ,abstr 8011)
  • 8Hida T, Okamoto I, Kashii T, et al. Randomized phase Ⅲ study of platinum-doublet chemotherapy followed by gefitinib versus continued platinum-doublet chemotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of West Japan Thoracic Oncology Group trial (WJTOG). J Clin Oncol, 2008, 26: (suppl; abstr LBA8012)
  • 9Westeel VI.Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.J Natl Cancer Inst, 2005,97:499
  • 10Belani CP, Barstis J, La Rocca RV et al. Meta-analysis of weekly paclitaxel as maintenance therapy for advanced non-small cell lung cancer patients following initial chemotherapy. Lung Cancer, 2005,49 (suppl 2):S33

同被引文献32

  • 1易峰涛,宋华志,李静.氩氦刀联合放疗治疗晚期肺肿瘤92例临床报告[J].生物医学工程研究,2005,24(2):125-125. 被引量:2
  • 2牛立志,何卫兵,郭子倩,张述平,贺轶松,左建生,徐克成.经皮冷消融治疗局部进展型非小细胞肺癌[J].中国交通医学杂志,2006,20(2):138-139. 被引量:7
  • 3陈书昌,陈建民,陈晔,李杏梅,洪安民.氩氦刀靶向冷冻联合化疗治疗中晚期非小细胞肺癌[J].山东医药,2007,47(15):56-57. 被引量:7
  • 4Vuoristo MS,Vihinen P,Skytt(a) T,et al.Carboplatin and vinorelbine combined with subcutaneous interleukin-2 in metastatic melanoma with poor prognosis.Anticancer Res,2009,29:1755-1759.
  • 5Grossi F,Aita M,Defferrari C,et al.Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer:a meta-analytical approach.Oncologist,2009,14:497-510.
  • 6Pirker R,Pereira JR,Szczesna A,et al.Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX):an open-label randomised phase Ⅲ trial.Lancet,2009,373:1525-1531.
  • 7Shimada K,Iwase K,Aono T,et al.A case of advanced mucinous cystadenocarcinoma of the pancreas with peritoneal dissemination responding to gemcitabine.Gan To Kagaku Ryoho,2009,36:995-998.
  • 8Kamath A,Yoo D,Stuart OA,et al.Rationale for an intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer.Recent Pat Anticancer Drug Discov,2009,4:174-179.
  • 9张积仁.美国Cryocare氩氦刀靶向治疗技术[J].Pioneer bioscience publishing Co 2003.
  • 10冯华松,聂舟山,段蕴铀,李泳群,韩志海,张新红,孟激光,李毅,张燕,温居一.氩氦刀冷冻消融联合化疗治疗晚期非小细胞肺癌253例[J].中国肿瘤,2007,16(11):898-901. 被引量:17

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部